Brief: ESTEVE Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights For Increlex, Except For USA
01/04/2025 12:02
April 1 (Reuters) - Eton Pharmaceuticals Inc ETON.O: ESTEVE: SIGNS LICENSE & SUPPLY AGREEMENT WITH ETON PHARMACEUTICALS WITH GLOBAL RIGHTS FOR INCRELEX, EXCEPT FOR USA Source text: ID:nPrev7YLCa Further company coverage: ETON.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer